Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ginkgo Bioworks Holdings Inc (DNA) vs Goodyear Tire & Rubber Co (GT) Price & Performance

Ginkgo Bioworks Holdings IncTrade
Goodyear Tire & Rubber CoTrade

Price performance (Past 24H)

Key statistics

Ginkgo Bioworks Holdings Inc vs Goodyear Tire & Rubber Co — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.06 (market cap $590.53M), while Goodyear Tire & Rubber Co trades at $6.69 (market cap $1.91B). The key difference: Goodyear Tire & Rubber Co is far larger — about 3.2× Ginkgo Bioworks Holdings Inc's market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, Goodyear Tire & Rubber Co nearer its low. Which is the better fit depends on your goals.

DNAGT
Market Cap
$590.53M$1.91B
Sector
HealthConsumer Cyclical
52-Week High
$16.14$11.54
52-Week Low
$5.48$5.58
Enterprise Value
$627.78M$9.22B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ginkgo Bioworks Holdings Inc

DNA trades at $9.05, down 0.44% on the day, reflecting ongoing investor caution. The technical outlook is bearish, while fundamentals show significant losses with a net income margin of -201.05% and negative cash flows. Recent earnings have been mixed, missing estimates in two of the last three quarters. Analyst sentiment is divided, with a slight lean toward buy ratings amid high volatility and operational challenges.

The outlook remains challenging due to persistent losses and cash burn, though analyst coverage suggests potential long-term value. Key risks include execution missteps and intense competition in biotechnology. Investment appeal hinges on future profitability improvements and successful business model execution.

Goodyear Tire & Rubber Co

Goodyear Tire & Rubber (GT) trades at $6.64, down 2.5% today, with a bearish technical signal and mixed quarterly earnings. The stock shows deep value metrics with a P/E of 4.69 and P/B of 0.64, but fundamental weakness persists with negative net income margin of -11.64% and ROE of -52.56%. Recent news includes a shift to the S&P SmallCap 600 and a $1.05 billion senior notes offering to strengthen liquidity.

The outlook remains challenging due to operational headwinds and declining revenue, though analyst consensus suggests 32% upside to the $8.75 price target. Key risks include sustained profitability issues and high debt, while potential catalysts include cost-saving initiatives and new contracts like NASA's lunar tire supply.

Returns comparison

Trailing returns across standard periods

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA

About Goodyear Tire & Rubber Co

Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.

Read more on GT